Viewing Study NCT02951767

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-02-22 @ 9:40 PM
Study NCT ID: NCT02951767
Status: COMPLETED
Last Update Posted: 2024-03-28
First Post: 2016-10-31
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti-PD-L1 View
None PD-L1 View
None MPDL3280A View
None PD-1 View
None bladder cancer View
None atezolizumab View
None Tecentriq View